About
Senolytics
Areas of Focus
Categories
Small Molecule PharmaceuticalMiddle East
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
71
By Phase
PHASE2: 2PHASE1: 1
By Status
UNKNOWN: 2TERMINATED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT05656521Lead Sponsor
101-PGC-005 for the Treatment of COVID-19
PHASE2Unknown
62 participants
Started: Jan 31, 2023 · Completed: Jun 30, 2023
NCT05619770Lead Sponsor
Study to Evaluate Pharmacokinetics, Safety & Tolerability of 101-PGC-005 in Healthy, Adult, Human Subjects
PHASE1Unknown
6 participants
Started: Oct 29, 2022 · Completed: Jan 15, 2023
NCT05195749Lead Sponsor
A Prospective, Phase II Study to Evaluate Safety of 101-PGC-005 ('005) for Moderate to Severe COVID-19 Disease Along With Standard of Care
PHASE2Terminated
3 participants
Started: Jan 13, 2022 · Completed: Feb 14, 2023
Locations (1)
Headquarters
Rehovot, Israel
Map
Loading map...